Biotech

Latest Articles

Eli Lilly hops deeper right into AI with $409M Hereditary Leap deal

.Eli Lilly has actually vaulted in to an AI-enabled drug invention bargain, partnering with RNA expe...

After FDA denial and cutbacks, Lykos chief executive officer is actually leaving behind

.Lykos CEO and also owner Amy Emerson is actually walking out, with main operating officer Michael M...

Novartis fires up new phase of Voyager contract along with $15M capsid offer

.Novartis is opening a new frontier in its cooperation along with Voyager Therapeutics, paying $15 m...

Lilly posts extra good data on its own every week insulin prospect

.On the heels of an FDA denial for its chief rivalrous Novo Nordisk, Eli Lilly is actually making he...

IN 8bio standstills stage 2 trial, lays off fifty percent of labor force

.Just a couple of months after dosing the initial individual in a phase 2 test for recently diagnose...

Lilly, Haya ink $1B biobuck excessive weight pact to search black genome

.Eli Lilly's look for obesity aim ats has led it to the darker genome. The Big Pharma has actually a...

ArsenalBio raises $325M, rotates away from former lead resource

.Collection Biosciences is actually moving on up. The tissue treatment business has actually added $...

Lilly- backed effective weight loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' cannabis use medication flunks stage 2b, driving Indivior to rethink $100M choice

.Aelis Farma's hopes of protecting an easy, positive choice on a $one hundred million choice payment...

ProKidney stops stage 3 test certainly not required for tissue treatment approval

.ProKidney has actually quit one of a set of phase 3 trials for its cell therapy for renal illness a...

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals called "spectacular" period 1/2 data for its own 31-valent pn...

Recursion's brain illness trial reveals insufficient documentation of effectiveness

.Recursion has discovered via an early test of its own tech-enabled strategy to medicine discovery, ...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it an instance of great chemistry: Acepodia, a biotech based upon Nobel Champion science, i...

Praxis epilepsy drug reduces seizures in phase 2 litigation

.Practice Preciseness Medicines has actually scored another midphase win in epilepsy this year, with...

Three directors resign as Dyne posts mixed records for DMD candidate

.After leaving a medical grip several years back, Dyne Rehab has actually uncovered new stage 1/2 in...

Arrowhead fires off period 3 information in rare metabolic health condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in advance of a prospective face-off with Ionis...

Pfizer, Valneva present lyme health condition shot efficient for 2nd enhancer

.Pfizer and Valneva might possess concerning 2 additional years to wait just before they create the ...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Fierce Biotech Editor-in-Chief and also Michelle...

New records show how Bayer's asundexian fell short to stop movements

.Bayer suspended the stage 3 test for its own aspect XIa prevention asundexian behind time in 2014 a...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own a number of sclerosis (MS) med tolebrutinib to the F...